These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21549638)

  • 21. Combining radioisotopic and blue-dye technique does not improve the false-negative rate in sentinel lymph node mapping for colorectal cancer.
    Tiffet O; Kaczmarek D; Chambonnière ML; Guillan T; Baccot S; Prévot N; Bageacu S; Bourgeois E; Cassagnau E; Lehur PA; Dubois F
    Dis Colon Rectum; 2007 Jul; 50(7):962-70. PubMed ID: 17468975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping: a comparative study.
    van der Zaag ES; Buskens CJ; Kooij N; Akol H; Peters HM; Bouma WH; Bemelman WA
    Eur J Surg Oncol; 2009 Oct; 35(10):1065-70. PubMed ID: 19261431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node mapping in colon cancer: current status.
    de Haas RJ; Wicherts DA; Hobbelink MG; Borel Rinkes IH; Schipper ME; van der Zee JA; van Hillegersberg R
    Ann Surg Oncol; 2007 Mar; 14(3):1070-80. PubMed ID: 17206482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical application of sentinel lymph node biopsy for staging, treatment and prognosis of colon and gastric cancer.
    Dragan R; Nebojsa M; Dejan S; Ivan P; Dragos S; Damir J; Predrag S; Vladan Z
    Hepatogastroenterology; 2009; 56(96):1606-11. PubMed ID: 20214202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
    Bilchik AJ; DiNome M; Saha S; Turner RR; Wiese D; McCarter M; Hoon DS; Morton DL
    Arch Surg; 2006 Jun; 141(6):527-33; discussion 533-4. PubMed ID: 16785352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.
    Stojadinovic A; Nissan A; Protic M; Adair CF; Prus D; Usaj S; Howard RS; Radovanovic D; Breberina M; Shriver CD; Grinbaum R; Nelson JM; Brown TA; Freund HR; Potter JF; Peretz T; Peoples GE
    Ann Surg; 2007 Jun; 245(6):846-57. PubMed ID: 17522508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sentinel lymph node mapping in colorectal cancer].
    Vajda K; Cserni G; Svébis M; Baltás B; Bori R; Tarján M
    Magy Seb; 2002 Dec; 55(6):375-7. PubMed ID: 12616823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The sentinel lymph node technique in colorectal cancer using in vivo dye--utility and limits].
    Burcoş T; Popa E; Stanilescu S; Cristian D; Jitea N; Barbulescu M; Tudor C; Popa I; Angelescu N
    Chirurgia (Bucur); 2007; 102(3):281-8. PubMed ID: 17687856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo sentinel lymph node mapping in colorectal cancer using a magnetic nanoparticle tracer to improve staging accuracy: a pilot study.
    Pouw JJ; Grootendorst MR; Klaase JM; van Baarlen J; Ten Haken B
    Colorectal Dis; 2016 Dec; 18(12):1147-1153. PubMed ID: 27218666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.
    Bertoglio S; Sandrucci S; Percivale P; Goss M; Gipponi M; Moresco L; Mussa B; Mussa A
    J Surg Oncol; 2004 Mar; 85(3):166-70. PubMed ID: 14991889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review.
    van de Lande J; Torrenga B; Raijmakers PG; Hoekstra OS; van Baal MW; Brölmann HA; Verheijen RH
    Gynecol Oncol; 2007 Sep; 106(3):604-13. PubMed ID: 17628644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
    Nagaraja V; Eslick GD
    Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current clinical status of sentinel lymph nodes in colon and proximal rectal cancer.
    Bembenek A
    Colorectal Dis; 2011 Nov; 13 Suppl 7():63-6. PubMed ID: 22098522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node mapping procedure in T1 colorectal cancer: A systematic review of published studies.
    Di Berardino S; Capolupo GT; Caricato C; Caricato M
    Medicine (Baltimore); 2019 Jul; 98(28):e16310. PubMed ID: 31305416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative sentinel lymph node mapping in patients with colorectal cancer.
    Ivanov K; Kolev N; Ignatov V; Madjov R
    Hepatogastroenterology; 2009; 56(89):99-105. PubMed ID: 19453037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer.
    Currie AC; Brigic A; Thomas-Gibson S; Suzuki N; Moorghen M; Jenkins JT; Faiz OD; Kennedy RH
    Eur J Surg Oncol; 2017 Nov; 43(11):2044-2051. PubMed ID: 28919031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sentinel lymph node biopsy in colorectal carcinoma].
    Bembenek A; Gretschel S; Ulmer C; Schlag PM
    Chirurg; 2004 Aug; 75(8):761-6. PubMed ID: 15232693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool.
    Gyorki DE; Sanelli A; Herschtal A; Lazarakis S; McArthur GA; Speakman D; Spillane J; Henderson MA
    Ann Surg Oncol; 2016 Feb; 23(2):579-84. PubMed ID: 26471491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indocyanine green fluorescence-guided sentinel node biopsy: a meta-analysis on detection rate and diagnostic performance.
    Xiong L; Gazyakan E; Yang W; Engel H; Hünerbein M; Kneser U; Hirche C
    Eur J Surg Oncol; 2014 Jul; 40(7):843-9. PubMed ID: 24613744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.